A citation-based method for searching scientific literature

Asahi Hishida, Tetsuro Terazawa, Toshiko Mamiya, Hidemi Ito, Keitaro Matsuo, Kazuo Tajima, Nobuyuki Hamajima. Cancer Epidemiol 2010
Times Cited: 22







List of co-cited articles
194 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income.
Colleen M McBride, Gerold Bepler, Isaac M Lipkus, Pauline Lyna, Greg Samsa, Jennifer Albright, Santanu Datta, Barbara K Rimer. Cancer Epidemiol Biomarkers Prev 2002
143
63

Psychological and behavioural impact of genetic testing smokers for lung cancer risk: a phase II exploratory trial.
Saskia C Sanderson, Steve E Humphries, Christina Hubbart, Eluned Hughes, Martin J Jarvis, Jane Wardle. J Health Psychol 2008
55
59

Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial.
J Audrain, N R Boyd, J Roth, D Main, N F Caporaso, C Lerman. Addict Behav 1997
83
54

An intervention study of smoking cessation with feedback on genetic cancer susceptibility in Japan.
Hidemi Ito, Keitaro Matsuo, Kenji Wakai, Toshiko Saito, Hiroshi Kumimoto, Katashi Okuma, Kazuo Tajima, Nobuyuki Hamajima. Prev Med 2006
44
50

Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change.
C Lerman, K Gold, J Audrain, T H Lin, N R Boyd, C T Orleans, B Wilfond, G Louben, N Caporaso. Health Psychol 1997
117
36

Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.
Serena Chao, J Scott Roberts, Theresa M Marteau, Rebecca Silliman, L Adrienne Cupples, Robert C Green. Alzheimer Dis Assoc Disord 2008
166
31

Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency.
Matthew J Carpenter, Charlie Strange, Yonge Jones, Marguerite R Dickson, Cindy Carter, M Allison Moseley, Gregory E Gilbert. Ann Behav Med 2007
65
31

Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial.
Theresa Marteau, Victoria Senior, Steve E Humphries, Martin Bobrow, Treena Cranston, Martin A Crook, Lorna Day, Maryam Fernandez, Rob Horne, Andrew Iversen,[...]. Am J Med Genet A 2004
138
31

Biomedical risk assessment as an aid for smoking cessation.
Raphaël Bize, Bernard Burnand, Yolanda Mueller, Myriam Rège Walther, Jacques Cornuz. Cochrane Database Syst Rev 2009
50
31


Responses to online GSTM1 genetic test results among smokers related to patients with lung cancer: a pilot study.
Saskia C Sanderson, Suzanne C O'Neill, Della Brown White, Gerold Bepler, Lori Bastian, Isaac M Lipkus, Colleen M McBride. Cancer Epidemiol Biomarkers Prev 2009
41
27

Can genetic risk information enhance motivation for smoking cessation? An analogue study.
Alison J Wright, David P French, John Weinman, Theresa M Marteau. Health Psychol 2006
38
22



Novel genes identified in a high-density genome wide association study for nicotine dependence.
Laura Jean Bierut, Pamela A F Madden, Naomi Breslau, Eric O Johnson, Dorothy Hatsukami, Ovide F Pomerleau, Gary E Swan, Joni Rutter, Sarah Bertelsen, Louis Fox,[...]. Hum Mol Genet 2007
468
22


Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.
Theresa M Marteau, David P French, Simon J Griffin, A T Prevost, Stephen Sutton, Clare Watkinson, Sophie Attwood, Gareth J Hollands. Cochrane Database Syst Rev 2010
200
22

Maximizing the motivational impact of feedback of lung cancer susceptibility on smokers' desire to quit.
C M McBride, S Halabi, G Bepler, P Lyna, L McIntyre, I Lipkus, J Albright, K O'Briant. J Health Commun 2000
34
18

A vision for the future of genomics research.
Francis S Collins, Eric D Green, Alan E Guttmacher, Mark S Guyer. Nature 2003
18

The genetics of nicotine addiction liability: ethical and social policy implications.
Wayne D Hall, Coral E Gartner, Adrian Carter. Addiction 2008
18
22

Effect of direct-to-consumer genomewide profiling to assess disease risk.
Cinnamon S Bloss, Nicholas J Schork, Eric J Topol. N Engl J Med 2011
352
18


The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis.
Gareth J Hollands, David P French, Simon J Griffin, A Toby Prevost, Stephen Sutton, Sarah King, Theresa M Marteau. BMJ 2016
264
18


Future health applications of genomics: priorities for communication, behavioral, and social sciences research.
Colleen M McBride, Deborah Bowen, Lawrence C Brody, Celeste M Condit, Robert T Croyle, Marta Gwinn, Muin J Khoury, Laura M Koehly, Bruce R Korf, Theresa M Marteau,[...]. Am J Prev Med 2010
105
13

Explaining behavior change after genetic testing: the problem of collinearity between test results and risk estimates.
Thomas R Fanshawe, A Toby Prevost, J Scott Roberts, Robert C Green, David Armstrong, Theresa M Marteau. Genet Test 2008
16
18

What does "a gene for heart disease" mean? A focus group study of public understandings of genetic risk factors.
Benjamin R Bates, Alan Templeton, Paul J Achter, Tina M Harris, Celeste M Condit. Am J Med Genet A 2003
59
13



Outcome criteria in smoking cessation trials: proposal for a common standard.
Robert West, Peter Hajek, Lindsay Stead, John Stapleton. Addiction 2005
789
13

Genomic priorities and public health.
Kathleen Ries Merikangas, Neil Risch. Science 2003
165
13



Chipping away at the genetics of smoking behavior.
Christopher I Amos, Margaret R Spitz, Paul Cinciripini. Nat Genet 2010
29
13

What can interest tell us about uptake of genetic testing? Intention and behavior amongst smokers related to patients with lung cancer.
S C Sanderson, S C O'Neill, L A Bastian, G Bepler, C M McBride. Public Health Genomics 2010
62
13



Has the revolution arrived?
Francis Collins. Nature 2010
167
13

Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking.
Sophia C L Whitwell, Christopher G Mathew, Cathryn M Lewis, Alastair Forbes, Sally Watts, Jeremy Sanderson, Gareth J Hollands, A Toby Prevost, David Armstrong, Ann Louise Kinmonth,[...]. BMC Public Health 2011
3
100

A smoking cessation programme for use in general practice.
R L Richmond, I W Webster. Med J Aust 1985
71
13

Lung cancer screening as a teachable moment for smoking cessation.
Kathryn L Taylor, Lisa Sanderson Cox, Nicole Zincke, Larina Mehta, Colleen McGuire, Edward Gelmann. Lung Cancer 2007
138
13

A randomized trial of smoking cessation interventions in general practice in Italy.
N Segnan, A Ponti, R N Battista, C Senore, S Rosso, S H Shapiro, D Aimar. Cancer Causes Control 1991
70
13

"Look at your health": outcomes associated with a computer-assisted smoking cessation counseling intervention for community college students.
Alexander V Prokhorov, Tracey Yost, Mary Mullin-Jones, Carl de Moor, Kentya H Ford, Salma Marani, Briseis A Kilfoy, Joshua P Hein, Karen Suchanek Hudmon, Karen M Emmons. Addict Behav 2008
48
13

Effects of physician counseling on the smoking behavior of asbestos-exposed workers.
V C Li, Y J Kim, C K Ewart, P B Terry, J C Cuthie, J Wood, E A Emmett, S Permutt. Prev Med 1984
53
13

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.
T F Heatherton, L T Kozlowski, R C Frecker, K O Fagerström. Br J Addict 1991
13


Mortality in relation to smoking: 50 years' observations on male British doctors.
Richard Doll, Richard Peto, Jillian Boreham, Isabelle Sutherland. BMJ 2004
13

[The effect of smoking cessation counseling at health checkup].
T Terazawa, T Mamiya, S Masui, M Nakamura. Sangyo Eiseigaku Zasshi 2001
22
13

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior.
Thorgeir E Thorgeirsson, Daniel F Gudbjartsson, Ida Surakka, Jacqueline M Vink, Najaf Amin, Frank Geller, Patrick Sulem, Thorunn Rafnar, Tõnu Esko, Stefan Walter,[...]. Nat Genet 2010
521
13

Biomedical risk assessment as an aid for smoking cessation.
Raphaël Bize, Bernard Burnand, Yolanda Mueller, Myriam Rège-Walther, Jean-Yves Camain, Jacques Cornuz. Cochrane Database Syst Rev 2012
53
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.